Live Quote · OTCARSUFHealthcare · Drug Manufacturers - Specialty & Generic

Fagron N.V.

$26.53▲ 0.00%(+$0.00)

TickerSpark Score

76/100

▌ Solid

83

Valuation

80

Profitability

70

Growth

88

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARSUF research report →

52-Week Range87% of range

Low

$23.50

Current

$26.53

High

$27.00

Company Overviewwww.fagron.com

About the company

Fagron N. V. is a specialized pharmaceutical compounding firm focused on delivering tailored medicinal solutions.

CEO: Rafael Padilla
IPO: 2017
Employees: 3,828
HQ: Nazareth, BE

Price Chart

+5.28% · this period

Valuation

Market Cap: $1.95B
P/E: 19.84
P/S: 1.89
P/B: 3.26
EV/EBITDA: 11.29
Div Yield: 1.63%

Profitability

Gross Margin: 51.47%
Op Margin: 15.50%
Net Margin: 9.56%
ROE: 17.29%
ROIC: 11.09%

Growth & Income

Revenue: $951.81M · 9.16%
Net Income: $90.99M · 12.95%
EPS: $1.24 · 12.73%
Op Income: $146.16M
FCF YoY: 63.52%

Performance & Tape

52W High: $27.00
52W Low: $23.50
50D MA: $26.53
200D MA: $25.34
Beta: 0.38
Avg Volume: 698

Get TickerSpark's AI analysis on ARSUF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · ARSUF